Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ginseng research

This article was originally published in The Tan Sheet

Executive Summary

Ginseng-induced blood glucose level reductions following a meal are time-dependent but not dose-dependent, Canadian researchers report in April American Journal of Clinical Nutrition. Vladimir Vuksan, University of Toronto, et al., administered placebo, 1 g, 2 g or 3 g American ginseng to 12 healthy subjects at 40, 20 or 10 minutes before, or simultaneous with, a 25 g oral glucose challenge. "American ginseng significantly lowers the postprandial glycemic response...from 9% to 15%," researchers report, noting "only when administration was 40 min. before the challenge were differences in glycemia observed." Doses within 1-3 g range were equally effective, Vuksan et al. found, suggesting future studies should examine lower doses and the botanical's "long-term efficacy, safety" as a diabetes therapy
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092371

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel